To be adequately equipped to distribute medicines throughout Canada, pharma firms must be fully educated on the bespoke pain points this region has to offer. Canada’s pharmaceutical market is primed to grow to $25 bn by 2021, according to consulting firm GlobalData. With a 2.5% share of the global market, Canada stands as the 10th largest pharma market. However, Canada has unique complications and hurdles, which greatly complicate the task of distributing temperature sensitive medicines within the region.
In this in-depth whitepaper, we explore the challenges and opportunities associated with achieving temperature supply chain excellence in Canada such as:
Please note: That all fields marked with an asterisk (*) are required.